Next Article in Journal
Triple Non-Statin Therapy with Ezetimibe, Inclisiran, and Bempedoic Acid in Patients with Genetically Confirmed Statin-Induced Rhabdomyolysis: A Dual Case Report
Previous Article in Journal
Correction: Lin et al. Huafengdan Inhibits Glioblastoma Cell Growth and Mobility by Acting on PLAU and CAV1 Targets. Pharmaceuticals 2025, 18, 428
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(6), 816; https://doi.org/10.3390/ph18060816
Action Date Notes Link
article xml file uploaded 29 May 2025 12:21 CEST Original file -
article xml uploaded. 29 May 2025 12:21 CEST Update https://www.mdpi.com/1424-8247/18/6/816/xml
article pdf uploaded. 29 May 2025 12:21 CEST Version of Record https://www.mdpi.com/1424-8247/18/6/816/pdf
article supplementary file uploaded. 29 May 2025 12:21 CEST - https://www.mdpi.com/1424-8247/18/6/816#supplementary
article html file updated 29 May 2025 12:23 CEST Original file https://www.mdpi.com/1424-8247/18/6/816/html
Back to TopTop